DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Bethanechol chlorideis the generic ingredient in four branded drugs marketed by Odyssey Pharms, Able, Actavis Elizabeth, Amneal Pharm, Ascot, Discovery Therap, Heritage Pharma, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lannett Co Inc, Sandoz, Sun Pharm Inds Inc, Upsher Smith Labs, Watson Labs, Wockhardt, Chartwell Rx, and Glenwood, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.
There are eight drug master file entries for bethanechol chloride. Ten suppliers are listed for this compound.
Recent Clinical Trials for bethanechol chloride
Identify potential brand extensions & 505(b)(2) entrants
|Rajavithi Hospital||Phase 4|
Pharmacology for bethanechol chloride
|Drug Class||Cholinergic Muscarinic Agonist |
|Mechanism of Action||Cholinergic Muscarinic Agonists |
Medical Subject Heading (MeSH) Categories for bethanechol chloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sun Pharm Inds Inc||BETHANECHOL CHLORIDE||bethanechol chloride||TABLET;ORAL||040897-001||Apr 22, 2009||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Watson Labs||BETHANECHOL CHLORIDE||bethanechol chloride||TABLET;ORAL||084402-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Wockhardt||BETHANECHOL CHLORIDE||bethanechol chloride||TABLET;ORAL||040518-001||Sep 29, 2003||AA||RX||No||No||Start Trial||Start Trial||Start Trial|
|Odyssey Pharms||URECHOLINE||bethanechol chloride||TABLET;ORAL||006536-003||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Discovery Therap||BETHANECHOL CHLORIDE||bethanechol chloride||TABLET;ORAL||040728-002||Oct 26, 2007||AA||RX||No||No||Start Trial||Start Trial||Start Trial|
|Amneal Pharm||BETHANECHOL CHLORIDE||bethanechol chloride||TABLET;ORAL||040855-004||Nov 21, 2007||AA||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.